For instance, studies on humans indicated slightly elevated levels of LCN-2 in the plasma of patients with mild cognitive impairment (Choi et al., 2011) and the local concentration of LCN-2 in the brain tissue of patients with multiple sclerosis (Al Nimer et al., 2016). This evidence concerns the gene LCN2 and multiple sclerosis.